McKesson Corporation (NYSE:MCK) Files An 8-K Costs Associated with Exit or Disposal Activities

McKesson Corporation (NYSE:MCK) Files An 8-K Costs Associated with Exit or Disposal Activities
Item 2.05 Costs Associated with Exit or Disposal Activities.

Story continues below

On April25, 2018, McKesson Corporation (the “Company”) announced a multi-year strategic growth initiative, focused on creating innovative solutions that improve patient care delivery and drive incremental profit growth. As an initial phase of this initiative, the Company committed to a restructuring plan to optimize its operating model and cost structure. The plan will encompass key functional areas such as information technology, finance and human resources and is expected to be substantially implemented prior to the end of the Company’s fiscal year ending March31, 2019.

As a result, the Company expects to record after-tax charges of approximately $150 million to $210 million during the fiscal year ending March31, 2019. The charges will primarily consist of employee severance, exit-related costs and other charges. The range is an estimate and actual charges may be higher or lower than the estimate.

Item 2.05 Regulation FD Disclosure.

On April25, 2018, the Company issued a press release reaffirming its adjusted earnings per diluted share guidance range for the fiscal year ended March31, 2018 and provided a preliminary adjusted earnings per diluted share guidance range for the fiscal year ending March31, 2019. A copy of the Company’s press release is attached hereto as Exhibit 99.1.

The information contained in this Form 8-K, including Exhibits 99.1, is furnished to the Securities and Exchange Commission (the “Commission”), but shall not be deemed “filed” with the Commission for purposes of Section18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing.

Item 2.05 Financial Statements and Exhibits.

(d)Exhibits.


MCKESSON CORP Exhibit
EX-99.1 2 d575359dex991.htm EX-99.1 EX-99.1 Exhibit 99.1   McKESSON LAUNCHES MULTI-YEAR STRATEGIC GROWTH INITIATIVE; REAFFIRMS FISCAL 2018 OUTLOOK AND PROVIDES PRELIMINARY FISCAL 2019 OUTLOOK   •   McKesson announces a multi-year growth initiative,…
To view the full exhibit click here

About McKesson Corporation (NYSE:MCK)

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

An ad to help with our costs